Traditional Chinese medicine research and development to upgrade independent innovation drive 
 
 
The 2014-10-14 09:21 
 
 
Source: wuzhou daily 
 
 
Our reporter li xin bowed the correspondent Michael into her 

        Used in the treatment of disease of heart head blood-vessel of vial thrombus, zhongheng wuzhou pharmaceutical (group) co., LTD. Is the core of the leading product, after company pharmaceutical technology center of research and development and promotion, its technical level in a leading position in the whole country. 
 
        For injection thrombus is TCM injections, main component is panax notoginseng total saponin. Wuzhou pharmaceutical group independent research and development to master the panax notoginseng total saponin extraction process, solved the difficult problem notoginseng total saponin preparation of water-soluble, product purity, safety and adverse drug reaction rate aspect all has the very high level. TCM injections at present, the overall level is not high, the product quality, safety, jagged environment, injection with thrombosis through market competitiveness is self-evident. 
 
        Injection with thrombosis of high technical level is not achieved overnight. "After 2000, we have injected with thrombosis through multiple upgrades, also made a new upgrade over the last two years. After the upgrade, injected with thrombus tong medicine has reached more than 90% purity, product quality has improved, the production is five times bigger than the old." Wuzhou Huang Yusheng pharmaceutical company deputy general manager said. 
 
        Huang Yusheng is introduced, the company will continue to pay attention to improve the injection with thrombosis of pharmacological effects, form a scientific theory support to upgrade the product, further improve the therapeutic efficacy of the product and technology content, expand product variety, let heart cerebrovascular disease patients get better drugs. 
 
        Injection with thrombosis of escalating is wuzhou pharmaceutical group adhere to independent innovation and development of the road of a microcosm. In recent years, the company continuously increasing investment, vigorously promote technological innovation, promote enterprise's core competitiveness. The company has established a pharmaceutical technology center, guangxi wuzhou drug purification engineering technology research center, the dosage forms of modern Chinese medicine research and development center and other scientific research institutions, committed to the core technology breakthrough, and with many universities and research institutions to carry out cooperation, continuous research and development to upgrade products, injection with thrombosis, fu phlogistic clean capsule, the paishi multiple products won the national invention patent certificate, and regarded as autonomous region high-tech products, the company also relies on science and technology innovation achievements won "national high-tech enterprise", "high-tech enterprises in guangxi", "outstanding science and technology enterprises" title. 
 
        Inherited and carries forward the advantages of traditional Chinese medicine characteristics, on the basis of wuzhou pharmaceutical group also make full use of modern science and technology, improve product technology content, to speed up the modern pharmaceutical technology application in Chinese traditional medicine production, the key breakthrough the large ultrafiltration equipment, purification of Chinese medicine effective component, Chinese medicine extract cryogenic freeze drying technology, development of biological technology, development of modern Chinese patent medicine and chemicals such as all kinds of new technology and products at the core of the key technologies. Liu Guanping group company research and development director, said the company focus on continuous innovation in science and technology innovation, new product research and development and the secondary development of the old ones. "Everybody is doing research and development, production efficacy better drugs, if no progress will be eliminated".
 
 
The original link: http://tech.gmw.cn/newspaper/2014-10/14/content_101420195.htm